Literature DB >> 10931137

Changed colonic profile of P-selectin, platelet-endothelial cell adhesion molecule-1 (PECAM-1), intercellular adhesion molecule-1 (ICAM-1), ICAM-2, and ICAM-3 in inflammatory bowel disease.

B Vainer1, O H Nielsen.   

Abstract

Cell adhesion molecules (CAM) are essential for the capture and migration of leucocytes. Ulcerative colitis (UC) and Crohn's disease (CD) are characterized by a continuous infiltration of leucocytes into intestinal tissue, and the colonic contents of P-selectin, PECAM-1, ICAM-1, ICAM-2, and ICAM-3 were therefore studied. Concentrations of these cell adhesion molecules were measured by an ELISA technique in sonicated colonic tissue from patients with UC and CD and controls with non-inflammatory disease and compared with the diagnosis and disease activity. P-selectin, PECAM-1, and ICAM-1 concentrations were elevated in UC patients compared with controls (P = 0.034, P = 0.014, P = 0.017, respectively), whereas that of ICAM-2 was not. The concentrations of these CAM did not differ in CD. In contrast, higher concentrations of ICAM-3 were found in the CD patients than in either UC (P = 0.001) or controls (P = 0.004). The CAM concentrations increased with disease activity, although only ICAM-1 was significantly elevated (P = 0.017). As considerable differences were found between UC and CD with comparable stages of inflammation, the mere presence of inflammation cannot solely explain the results. The observed differences in the CAM concentrations in UC and CD support the hypothesis that UC and CD are two distinct disease entities with separate pathogenic mechanisms.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10931137      PMCID: PMC1905699          DOI: 10.1046/j.1365-2249.2000.01296.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

1.  Comparative studies of the colonic in situ expression of intercellular adhesion molecules (ICAM-1, -2, and -3), beta2 integrins (LFA-1, Mac-1, and p150,95), and PECAM-1 in ulcerative colitis and Crohn's disease.

Authors:  B Vainer; O H Nielsen; T Horn
Journal:  Am J Surg Pathol       Date:  2000-08       Impact factor: 6.394

2.  Circulating L-selectin levels and endothelial CD34 expression in inflammatory bowel disease.

Authors:  J B Seidelin; B Vainer; T Horn; O H Nielsen
Journal:  Am J Gastroenterol       Date:  1998-10       Impact factor: 10.864

3.  In-situ endothelial cell adhesion molecule expression in ulcerative colitis. E-selectin in-situ expression correlates with clinical, endoscopic and histological activity and outcome.

Authors:  C Cellier; N Patey; G Fromont-Hankard; J P Cervoni; M Leborgne; S Chaussade; J P Barbier; N Brousse
Journal:  Eur J Gastroenterol Hepatol       Date:  1997-12       Impact factor: 2.566

4.  Expression of leukocyte adhesion molecules by mucosal mononuclear phagocytes in inflammatory bowel disease.

Authors:  G Malizia; A Calabrese; M Cottone; M Raimondo; L K Trejdosiewicz; C J Smart; L Oliva; L Pagliaro
Journal:  Gastroenterology       Date:  1991-01       Impact factor: 22.682

5.  Expression and polarization of intercellular adhesion molecule-1 on human intestinal epithelia: consequences for CD11b/CD18-mediated interactions with neutrophils.

Authors:  C A Parkos; S P Colgan; M S Diamond; A Nusrat; T W Liang; T A Springer; J L Madara
Journal:  Mol Med       Date:  1996-07       Impact factor: 6.354

Review 6.  Gastrointestinal inflammation. Inflammatory bowel disease in knockout mice.

Authors:  T T MacDonald
Journal:  Curr Biol       Date:  1994-03-01       Impact factor: 10.834

7.  Increased mucosal concentrations of soluble intercellular adhesion molecule-1 (sICAM-1), sE-selectin, and interleukin-8 in active ulcerative colitis.

Authors:  O H Nielsen; J Brynskov; B Vainer
Journal:  Dig Dis Sci       Date:  1996-09       Impact factor: 3.199

8.  Expression of intercellular adhesion molecule 1 (ICAM-1, CD54) in colonic epithelial cells.

Authors:  W Dippold; B Wittig; W Schwaeble; W Mayet; K H Meyer zum Büschenfelde
Journal:  Gut       Date:  1993-11       Impact factor: 23.059

9.  CD31/PECAM-1 is a ligand for alpha v beta 3 integrin involved in adhesion of leukocytes to endothelium.

Authors:  L Piali; P Hammel; C Uherek; F Bachmann; R H Gisler; D Dunon; B A Imhof
Journal:  J Cell Biol       Date:  1995-07       Impact factor: 10.539

10.  Serum Concentration and Chemotactic Activity of E-selectin (CD62E) in Inflammatory Bowel Disease.

Authors:  B Vainerc; O H Nielsen
Journal:  Mediators Inflamm       Date:  1994       Impact factor: 4.711

View more
  25 in total

Review 1.  Role of cell adhesion molecules in leukocyte recruitment in the liver and gut.

Authors:  A Ala; A P Dhillon; H J Hodgson
Journal:  Int J Exp Pathol       Date:  2003-02       Impact factor: 1.925

Review 2.  Anti-inflammatory treatment of uveitis with biologicals: new treatment options that reflect pathogenetic knowledge of the disease.

Authors:  Arnd Heiligenhaus; Stephan Thurau; Maren Hennig; Rafael S Grajewski; Gerhild Wildner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-08-25       Impact factor: 3.117

3.  ICAM-1, ICAM-2 and ICAM-3 in the sera of patients with idiopathic pulmonary fibrosis.

Authors:  Pelagia G Tsoutsou; Konstantinos I Gourgoulianis; Efthymia Petinaki; Maria Mpaka; Smaragda Efremidou; Antonios Maniatis; Pashalis Adam Molyvdas
Journal:  Inflammation       Date:  2004-12       Impact factor: 4.092

Review 4.  Multiple pathogenic roles of microvasculature in inflammatory bowel disease: a Jack of all trades.

Authors:  Livija Deban; Carmen Correale; Stefania Vetrano; Alberto Malesci; Silvio Danese
Journal:  Am J Pathol       Date:  2008-05-05       Impact factor: 4.307

5.  Anti-inflammatory effect of Diammonium Glycyrrhizinate in a rat model of ulcerative colitis.

Authors:  Hao Yuan; Wan-Sheng Ji; Ke-Xiang Wu; Jian-Xin Jiao; Liang-Hua Sun; Yong-Tang Feng
Journal:  World J Gastroenterol       Date:  2006-07-28       Impact factor: 5.742

6.  Amelioration of experimental colitis by Astragalus membranaceus through anti-oxidation and inhibition of adhesion molecule synthesis.

Authors:  Joshua-Ka-Shun Ko; Flora-Ying-Lee Lam; Andrew-Pok-Lap Cheung
Journal:  World J Gastroenterol       Date:  2005-10-07       Impact factor: 5.742

7.  Increased Cell Adhesion Molecules, PECAM-1, ICAM-3, or VCAM-1, Predict Increased Risk for Flare in Patients With Quiescent Inflammatory Bowel Disease.

Authors:  Phillip Gu; Arianne Theiss; Jie Han; Linda A Feagins
Journal:  J Clin Gastroenterol       Date:  2017-07       Impact factor: 3.062

8.  Expression of ICAM-1 in colon epithelial cells: an ultrastructural study performed on in vivo and in vitro models.

Authors:  Ben Vainer; Susanne Sørensen; Jakob Seidelin; Ole Haagen Nielsen; Thomas Horn
Journal:  Virchows Arch       Date:  2003-10-16       Impact factor: 4.064

9.  A randomised, controlled, double blind, escalating dose study of alicaforsen enema in active ulcerative colitis.

Authors:  S J H van Deventer; J A Tami; M K Wedel
Journal:  Gut       Date:  2004-11       Impact factor: 23.059

10.  Double blind, placebo controlled trial of the remission inducing and steroid sparing properties of an ICAM-1 antisense oligodeoxynucleotide, alicaforsen (ISIS 2302), in active steroid dependent Crohn's disease.

Authors:  B R Yacyshyn; W Y Chey; J Goff; B Salzberg; R Baerg; A L Buchman; J Tami; R Yu; E Gibiansky; W R Shanahan
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.